Literature DB >> 22115067

Assessment of herd immunity from human papillomavirus vaccination.

Johannes A Bogaards, Johannes Berkhof.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115067     DOI: 10.1016/S1473-3099(11)70324-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

Review 1.  An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls.

Authors:  Robine Donken; Johannes A Bogaards; Fiona R M van der Klis; Chris J L M Meijer; Hester E de Melker
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

2.  Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.

Authors:  F Lamb; E Herweijer; A Ploner; I Uhnoo; K Sundström; P Sparén; L Arnheim-Dahlström
Journal:  BMJ Open       Date:  2017-06-08       Impact factor: 2.692

3.  The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.

Authors:  Joanna Jackowska; Anna Bartochowska; Michał Karlik; Mateusz Wichtowski; Maciej Tokarski; Małgorzata Wierzbicka
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

4.  Quantifying the decisional satisfaction to accept or reject the Human Papillomavirus (HPV) vaccine: a preference for cervical cancer prevention.

Authors:  Diane M Harper; Billy B Irons; Natalie M Alexander; Johanna C Comes; Melissa S Smith; Melinda A Heutinck; Sandra M Handley; Debra A Ahern
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

Review 5.  Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies.

Authors:  Amira H Bakir; Martin Skarzynski
Journal:  Front Public Health       Date:  2015-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.